5WA — OUE Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- SG$111.08m
- SG$975.06m
- SG$152.39m
Annual cashflow statement for OUE Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 111 | 32.5 | 57.5 | 25.6 | 8.57 |
| Depreciation | |||||
| Non-Cash Items | -108 | 32.5 | 20.4 | 48.1 | 58.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.221 | -14.9 | -14.5 | -15.4 | -13.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.09 | 51.6 | 65.5 | 60.7 | 56.4 |
| Capital Expenditures | -0.954 | -0.61 | -0.477 | -0.605 | -1.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -29 | 43.8 | -62.4 | 19.3 | 10.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -30 | 43.2 | -62.8 | 18.7 | 9.03 |
| Financing Cash Flow Items | -3.11 | -66.2 | -61.1 | -59.1 | -52.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.03 | -67.9 | -8.09 | -68.2 | -49.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -25.1 | 23.1 | -7.26 | 10.3 | 14 |